Bundle and Save
Quickly becoming the Professional’s Choice, this easy to use, portable handheld device is guaranteed to elevate the standards of oral health assessment and patient care. Get Started TODAY with the Value Bundle, contact your preferred distributor for special pricing.
Learn More!
New Patient Generating Marketing Program
Join the Movement. Are you saving lives? Let the world know! Jump start patient oral cancer awareness and new patient generation with a dedicated practice landing page, creative assets for your social media channels, digital signage, and more.
Learn More!

early detection can save lives

We are LED Dental. We design innovative solutions to help you care for your patients and grow your practice. 
Contact us today.

Award-Winning Oral Screening and Imaging Technology

For the past 15 years we have been passionate in our commitment to the importance of oral mucosal screening and the sometime lifesaving benefits that fluorescence visualization with VELscope can bring when incorporated into your comprehensive oral examinations.

Our VELscope® VELscope Enhanced Oral Assessment System has been helping clinicians visualize oral mucosal abnormalities, including oral cancer, since its launch in 2006. The VELscope has changed the oral mucosal screening landscape.

.

The VELscope offers hope for the early discovery of oral disease, including precancer and cancer.

Oral Cancer 5 Year Relative Survival Rate

83%

If Found Early

40%

If Found Late

VELscope not only enhances visualization of cancer related lesions but also many other types of more common abnormalities which when found promptly and dealt with appropriately can improve patient health and benefit quality of life.

There’s no reason not to make it part of your practice’s standard of care.

VELscope Technology

The VELscope Enhanced Oral Assessment System is centered on a handheld scope that is used by clinicians to illuminate oral tissues with blue light and visualize the resulting natural tissue fluorescence.  This fluorescence enhances the traditional oral examination by allowing visualization of abnormal areas that may not have been apparent or even visible to the naked eye.

The VELscope system is an adjunctive device which means it must be used together with and as a supplement to the traditional intra and extraoral head and neck exam. Unlike other adjunctive devices used for oral examinations, the VELscope does not require any dyes or prolonged testing procedures. In fact, a VELscope exam can be performed in the dentist’s office during a routine hygiene exam in about two minutes.

 

Whether you begin your journey on our courses website or choose the flexibility of video learning, our courses are designed to help you along your path.

A New Way to Examine for Oral Disease

VELscope technology is changing the way oral mucosal examinations take place. The VELscope handheld device emits a harmless, bright blue light which is used to inspect the mouth and tongue. The device is sensitive to abnormal tissue changes and the distinctive blue-spectrum light causes the soft tissue (oral mucosa) of the mouth to naturally fluoresce. Healthy tissues fluoresce in distinct patterns that may be visibly disrupted when tissue undergoes an abnormal change (which can occur in the oral mucosa for a multitude of reasons) such as when associated with dysplasia or oral cancer.

Supplementing the COE

Dental practices use the VELscope device to supplement the comprehensive oral exam (“COE”, also referred to as an intra and extraoral head and neck exam), and they are rapidly embracing the use of this device to help visualize abnormal oral tissue such as cancerous or pre-cancerous tissues that are sometimes not apparent or even visible to the naked eye. This enhanced examination increases the chance that all suspicious areas are identified so that they can be investigated to establish an appropriate diagnostic or treatment protocol and rule out serious pathology like dysplasia or cancer.

Why Early Discovery Matters?

The statistics are highly suggestive: when discovered early the 5-year relative survival rate for oral cancer patients is about 83%. Unfortunately, most cases of oral cancer are discovered in late stages when the five-year relative survival rate drops to around 40 percent. Using the VELscope in everyday practice facilitates early discovery of abnormalities and increases the chance of a better prognosis for the patient should biopsy confirm the presence of dysplasia or cancer.

Changing Demographics

New research confirms that the risk factors for oral cancer have been expanded to include exposure to the Human Papilloma Virus (HPV16), in addition to tobacco use, frequent and/or excessive alcohol consumption, a compromised immune system, and past history of cancer. This changing demographic presents an unprecedented call to action for oral cancer awareness and regular screenings.

Training & Support

Award-Winning Oral Screening and Imaging Technology

VELcare

VELcare provides 100% coverage for Handpiece and Charging Cradle repairs due to manufacturer’s defect.

To learn more, give us a call.

What is oral cancer, the condition John Farnham is being treated for?

John Farnham is in a stable condition in intensive care after undergoing surgery to remove an oral...

Diagnose HPV-driven oropharyngeal cancer

Accuracy of high-risk HPV DNA PCR, p16(INK4a)immunohistochemistry or the combination of both to...

World head and neck cancer day

World Head and Neck Cancer Day, the health agencies say it’s a timely opportunity to raise...

.

Latest News

(Visited 6,955 times, 4 visits today)
Close